|
|
Article: Takeda's 2005/6 income reaches 313.2B yen.(Takeda Chemical Industries Ltd.)
- Article from:
- Pharma Marketletter
- Article date:
- May 22, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Japanese drugmaker Takeda says that for the year ended March 31, 2006, its net income rose 12.9% to 313.2 billion yen ($2.84 billion), which it ascribes to profits derived from the transfer of shares of non-pharmaceutical businesses and Wyeth KK, which it co-owns with US major Wyeth (Marketletter April 17). Turnover for the period was up 7.9% to 1,212.2 billion yen, while the firm's operating income increased 4.6% to 402.8 billion yen, exceeding the target of 380.0 billion yen it announced last year.
Core product expansion leads the way
Revenue from in-house prescription drugs, which include the sales of unconsolidated affiliates and exports to ...
Related newspaper, magazine, and journal articles:
|
|
Article: Will Yen Weakness Trigger Intervention?
Global Finance;
January 1, 2006 ;
700+ words
... ... hands-off policy on the falling yen, US automakers will have issue with the weakness of the yen, as will the National Association ... strategy-Americas at HSBC Bank (USA) in New York. "To the extent ... true that the decline of the yen puts China at a competitive disadvantage ...
|
|